ストックスクリーナーアプリを入手
0.7302
44.68%
-0.5898
アフターアワーズ：
.68
-0.0502
-6.87%
前日終値:
$1.32
開ける：
$0.9856
24時間の取引高:
194.65M
Relative Volume:
6.89
時価総額：
$35.82M
収益：
-
当期純損益:
$-16.26M
株価収益率:
-0.6181
EPS:
-1.1814
ネットキャッシュフロー:
$-13.50M
1週間 パフォーマンス:
+206.94%
1か月 パフォーマンス:
+200.87%
6か月 パフォーマンス:
+24.16%
1年 パフォーマンス:
-77.53%
1日の値動き範囲:
$0.70
$1.15
1週間の範囲:
$0.23
$1.74
52週間の値動き範囲:
$0.1853
$3.40
Intensity Therapeutics Inc Stock (INTS) Company Profile
名前
Intensity Therapeutics Inc
セクター
電話
203-221-7381
住所
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.7302 | 64.75M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Intensity Therapeutics Inc (INTS) 最新ニュース
How interest rate cuts could boost Intensity Therapeutics Inc. stockJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Using Bollinger Bands to evaluate Intensity Therapeutics Inc.Quarterly Performance Summary & Weekly High Return Stock Opportunities - newser.com
How to track smart money flows in Intensity Therapeutics Inc.2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
Does Intensity Therapeutics Inc. show high probability of rebound2025 Key Highlights & Precise Buy Zone Tips - newser.com
Ranking Intensity Therapeutics Inc. among high performing stocks via tools2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
How Intensity Therapeutics Inc. stock performs in stagflationJuly 2025 Review & Low Drawdown Trading Strategies - newser.com
How Intensity Therapeutics Inc. stock trades before earnings2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset - MSN
Intensity Therapeutics Stock Price, Quotes and Forecasts - Benzinga
Intensity Therapeutics Enters Securities Purchase Agreement - TipRanks
INTS to raise $4.0M via 5,000,000-share registered direct sale - Stock Titan
Intensity Therapeutics prices $4 million registered direct offering By Investing.com - Investing.com South Africa
Intensity Therapeutics announces pricing of $4M registered direct offering of common stock - MSN
Intensity Therapeutics Prices $4 Million Direct Offering - MarketScreener
Intensity Therapeutics prices 5M shares at 80c in registered direct offering - TipRanks
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
Intensity Therapeutics, Inc. (INTS) stock tumbles 30% as $4M direct offering sparks investor concern - parameter.io
Unexpected Surge: Analyzing INTS Performance - timothysykes.com
Intensity Therapeutics prices $4 million registered direct offering - Investing.com
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Biotech Bombshell: Intensity Therapeutics (INTS) Surges Nearly 400% on Major Cancer Trial News - ts2.tech
Intensity Therapeutics stock tumbles after pricing $4 million offering By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock tumbles after pricing $4 million offering - Investing.com
Intensity Therapeutics stock up nearly 400% on solid tumour data - Yahoo Finance
Intensity Therapeutics (Nasdaq: INTS) prices $4M registered direct, selling 5M shares - Stock Titan
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Why Intensity Therapeutics Inc. stock is favored by top institutionsWeekly Market Report & AI Optimized Trade Strategies - newser.com
Trending tickers: Apple, Amazon, Netflix, Reddit and Intensity Therapeutics - Yahoo! Finance UK
Volume spikes in Intensity Therapeutics Inc. stock – what they meanMarket Sentiment Review & Technical Entry and Exit Alerts - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis toolsEarnings Miss & Verified Trade Idea Suggestions - newser.com
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know - inkl
US Stock Market top gainers and losers on October 30: Intensity Therapeutics, Inc. sees nearly 400% jump, - The Economic Times
Positive Phase 1/2 clinical data for cancer candidate drug propels Intensity Therapeutics (INTS.US) stock up by 395%. - 富途牛牛
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Intensity Therapeutics Shares Soar on Promising Cancer Trial Results - El-Balad.com
Intensity Therapeutics publishes cancer treatment study results in Lancet journal By Investing.com - Investing.com South Africa
Intensity Therapeutics shares skyrocket after strong cancer drug trial results - Business Upturn
Intensity Therapeutics shares more than double on promising cancer trial data - TradingView
Intensity Therapeutics Inc (INTS) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):